Drugs
Conditions
News and resources
MIMS Supported ResourcesEsketamine superior to quetiapine in refractory depression study
Researchers found esketamine nasal spray to be more effective than extended-release quetiapine in adults with treatment-resistant depression taking an SSRI or SNRI.
To continue enjoying this article, please sign in. You can register for free for limited further access, or subscribe now for full access to all our content. View our subscription and registration options.